Latest News


Policy Options to Reduce Prescription Drug Costs Across Medicare, Medicaid, and Commercial Insurance

October 1, 2024. Kavitha Patel, MD, MS, and Kevin Schulman, MD, MBA, argue that comprehensive reforms – such as expanding Medicare's negotiation power, reforming Medicaid drug rebates, and other sensible policy solutions – are critical to safeguarding the financial health of Medicare and ensuring that millions of beneficiaries can access the medications they need without facing undue financial hardship.